Effects of continuous stem cell factor administration on normal and erythropoietin-stimulated murine hemopoiesis: experimental results and model analysis

Stem Cells
G de HaanM Loeffler

Abstract

The aim of this study was to determine how stem cell factor (SCF) modifies hemopoietic cell production. First we determined the effects of a prolonged SCF administration on murine hemopoiesis and analyzed the results by a mathematical simulation model of hemopoiesis in order to explain the data. Subsequently we investigated the effects of simultaneous coadministration of SCF+erythropoietin (Epo), to see how effects of early and late cytokines superimpose. SCF administration during 14 days induced a proliferative wave through the hemopoietic system; colony forming units-granulocyte macrophage (CFU-GM), burst forming units-erythroid (BFU-E) and colony forming units erythroid (CFU-E) were the first to be augmented, followed by their respective progeny, ultimately leading to increased blood cell numbers. Despite continued treatment most cell numbers returned to normal values in 14 days, colony forming units-spleen (CFU-S), however, remained elevated. This wave pattern could be explained within the framework of a previously established mathematical model of hemopoiesis, if it was assumed that SCF affected the cycling status of primitive cells and if regulatory feedback loops of erythroid and myeloid progenitors on these cells were a...Continue Reading

References

Jan 1, 1976·American Journal of Hematology·H Hara, M Ogawa
Jan 1, 1992·Toxicology·S SchedingH E Wichmann
Oct 5, 1990·Cell·D E WilliamsH S Boswell
May 1, 1991·The Journal of Experimental Medicine·P de VriesD E Williams
Jul 1, 1991·The Journal of Experimental Medicine·M OgawaS Nishikawa
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D Metcalf, N A Nicola
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G MigliaccioJ W Adamson
Jan 1, 1989·Cell and Tissue Kinetics·M LoefflerH E Wichmann
Jan 1, 1985·Journal of Cancer Research and Clinical Oncology·P D WickramanayakeH E Wichmann

❮ Previous
Next ❯

Citations

Jan 26, 1999·Cytokine & Growth Factor Reviews·I Kushner
Aug 2, 2005·Blood Cells, Molecules & Diseases·Giovanni AmabileGiovanni Migliaccio
Jan 1, 2001·The Journal of Biological Chemistry·T J PircherD M Wojchowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2021 Meta ULC. All rights reserved